Weight-loss drugs alone are a 'bad answer' to the UK's obesity crisis

The UK government's Chief Medical Officer, Sir Chris Whitty, issued a warning that relying solely on new weight-loss drugs to combat the obesity epidemic would be a serious mistake and a 'societal failure'. In a speech delivered at a scientific conference in London, the expert emphasized that while drugs such as semaglutide (Wegovy) or tirzepatide (Mounjaro) are effective, they are not a magic solution to the problem. In his view, pharmacotherapy should only be an addition to a comprehensive strategy, whose foundation remains prevention, promotion of healthy eating, and increasing the population's physical activity. Obesity has been recognized as a global epidemic since the end of the 20th century, and its prevalence has nearly tripled since 1975. In the United Kingdom, the problem affects over a quarter of adults, and the costs of treating diseases related to overweight are estimated at billions of pounds annually. Whitty pointed to practical limitations of pharmacotherapy, including the high cost of drugs and the necessity of their long-term, often lifelong, use to maintain effects. In his opinion, even if costs were to fall, mass prescription of these agents would not be sustainable for the healthcare system and would not address the root causes of the crisis. „Relying on drugs as the main answer to obesity would be a societal failure.” — Sir Chris Whitty Instead, he called for systemic actions that would change the 'environmental determinants of health'. This means introducing regulations that make choosing unhealthy food more difficult and choosing healthy food easier. Among the proposed solutions were restrictions on marketing of ultra-processed foods targeted at children, product reformulation to reduce sugar, salt, and saturated fat content, and changes in urban planning promoting walking and cycling. The Chief Medical Officer also reminded that obesity is the leading preventable cause of many serious diseases, including cancers, heart disease, strokes, and type 2 diabetes. This places a significant burden on the National Health Service (NHS). Whitty stressed that while individual responsibility is important, the government and society have a duty to create conditions where the healthy choice becomes easier. His speech was received as a clear signal to policymakers not to treat new drugs as a cheap excuse for abandoning more difficult, systemic reforms in the area of public health.